Acute myeloid leukemia patients’ clinical response to idasanutlin (RG7388) is associated with pre-treatment MDM2 protein expression in leukemic blasts
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
格式: | 文件 |
语言: | English |
出版: |
Ferrata Storti Foundation
2016-05-01
|
丛编: | Haematologica |
在线阅读: | https://haematologica.org/article/view/7719 |